novartis semaglutide Readout newsletter: Obesity drug spending, Novo Nordisk and insulin Sem-P (Semaglutide) 4mg/3ml by Getz

A number of studies have shown it could significantly help lower the dose of insulin such patients need (Edwards, Li, Linvay

Any platform that approves prescriptions for patients with a BMI below 27 without documented comorbidities, or that skips intake review entirely and auto-approves all submissions, is operating outside accepted clinical standards

What to know about Ozempic and kidney disease The relationship between Ozempic and kidney disease is unclear

Some days will be easier than others, so try not to get discouraged if it takes longer than you expect for your new habits to stick

Curr Obes Rep 14 , 34 (2025)

Research-grade peptides from questionable sources may be cheaper but carry risks